Due not least to the BSE-crisis in Great Britian and the new variant of Creutzfeldt-Jakob disease (vCJD) a great need for a reliable diagnostic method of prion proteins exists, especially for the discrimination of prion cases from other neurodegenerative diseases. The present invention provides a method for the purification of recombinant prion proteins (rPrP), which are suitable to be used in the currently accepted detection method (Real-time quaking induced conversion, RT-QuIC) and lead to faster, more specific and overall more reliable results. Therefore, a ready-to use protein is provided for the detection of prion protein in blood, brain and cerebrospinal fluid (CSF).
Further information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
email@example.com | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy